A New York dermatologist coined the phrase “Ozempic face” to explain the sagging, deflated facial options that develop after weight reduction achieved with the drug semaglutide, a glucagon-like peptide, or GLP-1, agonist offered by Novo Nordisk as Ozempic for sort 2 diabetes or Wegovy for weight reduction. Ozempic customers usually lose 10-16 kilos, extra with the higher-dose Wegovy. The medicine are injected as soon as weekly, accompanied by nausea and vomiting in 50% of customers, can enhance threat for thyroid most cancers and pancreatitis, and price round $1000-$1500 per 30 days. Though initially permitted just for sort 2 diabetes, the burden loss impact has precipitated a scarcity of the medicine in some places, since folks desirous to shed extra pounds have emptied pharmacies.
However this phenomenon highlights a number of drawbacks of shedding weight by this route:
- GLP-1 medicine work by lowering urge for food and thereby calorie consumption. Weight reduction achieved by lowered calorie consumption are related to lack of muscle. For each 10 kilos misplaced, about 3 kilos are from muscle loss. This isn’t a benign phenomenon, as it’s related to lowered metabolic charge that makes future weight reduction harder, generally unattainable. It’s also related to elevated mortality, regardless of the advantages of fats loss.
- Many of the fats misplaced is from subcutaneous fats within the buttocks, thighs, chest, arms, and, sure, face, much less misplaced from stomach visceral fats. It is a drawback as a result of almost all the issues related to obese and weight problems usually are not attributable to subcutaneous however to stomach visceral fats. Belly fats that surrounds the intestines, liver, pancreas, and so on. is accountable for many of the well being issues related to extra weight akin to insulin resistance, hormonal disruption, and elevated potential for sort 2 diabetes, hypertension, coronary heart illness, cancers, and cognitive decline/dementia. Weight reduction with GLP-1 agonist medicine improves modestly on this profile with an approximate 50:50 lack of subcutaneous:visceral fats. As a result of there may be subcutaneous fats misplaced with most weight loss program and GLP-1 agonists, the lack of facial fats is a matter that may present the looks of accelerated getting old.
After all, dermatologists are stumped since their considering not often goes past topical steroids and filler injections. They’re subsequently advising folks with the sagging pores and skin of Ozempic face to endure pricey beauty procedures to treatment the looks of accelerated getting old. It’s the everyday healthcare paradigm: “deal with” with prescription drugs and procedures, then introduce extra prescription drugs and procedures to repair the issues that outcome. In spite of everything, healthcare is about cash, not well being.
Wouldn’t or not it’s higher to shed extra pounds with a technique that particularly favors lack of stomach visceral fats and thereby yields better metabolic enhancements whereas not inflicting lack of subcutaneous fats out of your face? You obtain this by addressing insulin resistance via modifications in weight loss program (eliminating meals that provoke insulin akin to wheat, grains, sugars), addressing widespread nutrient deficiencies akin to magnesium, omega-3 fatty acids, iodine, and vitamin D that affect insulin responses, then managing your gastrointestinal microbiome, i.e., all of the methods we use in my packages and outlined in my books and DrDavisInfiniteHealth.com web site. There may be subsequently much less lack of subcutaneous fats from areas such because the face, since normalizing insulin responsiveness favors lack of stomach fats. There may be additionally little to no lack of muscle mass.
Go a couple of steps additional and have interaction in methods that enhance dermal collagen and protect or enhance muscle mass, as outlined on this earlier weblog publish. Shedding pounds this manner is cheap, yields an extended record of different well being advantages, no pricey fillers or different procedures required to compensate.
